← Leaderboards
James C Oates
Medical University Of South Carolina
$6,188,464
Attributed
$9,065,953
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,957,203 · 19
VA$0 · 2
By mechanism
P30$6,405,454 · 6
R01$4,696,366 · 2
K08$635,300 · 1
R21$126,000 · 1
M01$94,083 · 9
I01$0 · 2
Top collaborators
- Gary S. Gilkeson6 shared
- Brad H Rovin5 shared
- Betty P. Tsao5 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Carlos F Salinas$4,519,272
- Caroline Westwater$4,723,443
- Edwin A Smith$1,741,845
- Xian Zhang$1,937,483
- Tamara K Nowling$698,616
Others in their field
Top investigators on “Systemic Lupus Erythematosus”
- Ignacio E. Sanz · University Of Rochester$57,737,718
- George C Tsokos · Beth Israel Deaconess Medical Center$37,219,358
- David Wofsy · University Of California, San Francisco$36,472,228
- Betty Diamond · Feinstein Institute For Medical Research$32,406,714
- John Barker Harley · Cincinnati Va Medical Center Research$30,355,689
- Patrick M Gaffney · University Of Minnesota Twin Cities$27,964,103
Research focus
Systemic Lupus ErythematosusFundingLupusLupus NephritisBaseClinical ResearchResourcesPhenotypeResponseResearch PersonnelNitric OxideKidneySamplingCommunitiesGenesBiological MarkersMorbidity - Disease RateFutureRheumatologyInflammationPathway InteractionsGeneticKidney DiseasesProduction
Grant awards (60)
Improving Minority Health in Rheumatic Disease (IMHeaRD)$659,475
P30 · FY2025 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$219,825
P30 · FY2025 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$219,825
P30 · FY2025 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis$0
I01 · FY2025 · VA · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$735,826
P30 · FY2024 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$312,690
P30 · FY2024 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$165,515
P30 · FY2024 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis$0
I01 · FY2024 · VA · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$745,031
P30 · FY2023 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$321,896
P30 · FY2023 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$165,514
P30 · FY2023 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis$0
I01 · FY2023 · VA · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$750,918
P30 · FY2022 · AR · contact PI
Predictive Biomarkers for disease activity and organ damage in patients with lupus$582,534
R01 · FY2022 · AR
Improving Minority Health in Rheumatic Disease (IMHeaRD)$327,783
P30 · FY2022 · AR · contact PI
Improving Minority Health in Rheumatic Disease (IMHeaRD)$165,514
P30 · FY2022 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis$0
I01 · FY2022 · VA · contact PI
Predictive Biomarkers for disease activity and organ damage in patients with lupus$628,779
R01 · FY2021 · AR
Resource Core$309,685
P30 · FY2021 · AR · contact PI
Predictive Biomarkers for disease activity and organ damage in patients with lupus$653,985
R01 · FY2020 · AR
Resource Core$309,685
P30 · FY2020 · AR · contact PI
Predictive Biomarkers for disease activity and organ damage in patients with lupus$642,740
R01 · FY2019 · AR
Resource Core$316,194
P30 · FY2019 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Systemic Lupus Erythematosus$0
I01 · FY2019 · VA · contact PI
Predictive Biomarkers for disease activity and organ damage in patients with lupus$667,800
R01 · FY2018 · AR
Resource Core$335,291
P30 · FY2018 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Systemic Lupus Erythematosus$0
I01 · FY2018 · VA · contact PI
Resource Core$344,787
P30 · FY2017 · AR · contact PI
Targeting Pathogenic Endothelial Dysfunction in Systemic Lupus Erythematosus$0
I01 · FY2017 · VA · contact PI
Targeting Pathogenic Endothelial Dysfunction in Systemic Lupus Erythematosus$0
I01 · FY2016 · VA · contact PI
Urine biomarkers of lupus nephritis pathology and response to therapy$0
I01 · FY2013 · VA · contact PI
Role of reactive intermediates in lupus nephritis$324,650
R01 · FY2012 · AR · contact PI
Urine biomarkers of lupus nephritis pathology and response to therapy$0
I01 · FY2012 · VA · contact PI
Role of reactive intermediates in lupus nephritis$275,184
R01 · FY2011 · AR · contact PI
Role of reactive intermediates in lupus nephritis$37,981
R01 · FY2011 · AR · contact PI
Urine biomarkers of lupus nephritis pathology and response to therapy$0
I01 · FY2011 · VA · contact PI
Urine biomarkers of lupus nephritis pathology and response to therapy$0
I01 · FY2011 · VA · contact PI
Role of reactive intermediates in lupus nephritis$286,650
R01 · FY2010 · AR
Role of reactive intermediates in lupus nephritis$293,899
R01 · FY2009 · AR
Role of reactive intermediates in lupus nephritis$302,164
R01 · FY2008 · AR
BIOMARKERS OF ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)$12,400
M01 · FY2008 · RR · contact PI
PROTEOMIC APPROACH TO URINE BIOMARKERS OF DISEASE IN LUPUS NEPHRITIS$6,975
M01 · FY2008 · RR · contact PI
THE ROLE OF NITRIC OXIDE AND EICOSANOIDS IN LUPUS NEPHRITIS$2,712
M01 · FY2008 · RR · contact PI
THE ROLE OF NITRIC OXIDE AND EICOSANOIDS IN LUPUS NEPHRITIS$6,571
M01 · FY2007 · RR · contact PI
PROTEOMIC APPROACH TO URINE BIOMARKERS OF DISEASE IN LUPUS NEPHRITIS$4,045
M01 · FY2007 · RR · contact PI
Role of nitric oxide and eicosanoids in lupus nepthritis$133,385
K08 · FY2005 · AR
Urine protein markers of disease in lupus nephritis$63,000
R21 · FY2005 · AR
THE ROLE OF NITRIC OXIDE AND EICOSANOIDS IN LUPUS NEPHRITIS$18,990
M01 · FY2005 · RR
THE ROLE OF NITRIC OXIDE IN SYSTEMIC SCLEROSIS$612
M01 · FY2005 · RR
Role of nitric oxide and eicosanoids in lupus nepthritis$130,129
K08 · FY2004 · AR
Urine protein markers of disease in lupus nephritis$63,000
R21 · FY2004 · AR
The Role of Nitric Oxide in SLE$41,778
M01 · FY2004 · RR
Role of nitric oxide and eicosanoids in lupus nepthritis$126,968
K08 · FY2003 · AR
Role of nitric oxide and eicosanoids in lupus nepthritis$123,899
K08 · FY2002 · AR
ROLE OF NITRIC OXIDE IN LUPUS$0
M01 · FY2002 · RR
Role of nitric oxide and eicosanoids in lupus nepthritis$120,919
K08 · FY2001 · AR
ROLE OF NITRIC OXIDE IN LUPUS$0
M01 · FY2001 · RR
ROLE OF NITRIC OXIDE IN LUPUS$0
M01 · FY2001 · RR
ROLE OF NITRIC OXIDE IN LUPUS$0
M01 · FY2001 · RR
ROLE OF NITRIC OXIDE IN LUPUS$0
M01 · FY2000 · RR